The Limits of Equivalents – Learnings from Salts v Pelican for Med-Tech Patent Protectio...
For almost a decade, the doctrine of equivalents has been a powerful tool available to UK patentees. Following Actavis v Lilly, patent owners took comfort in...
Read more >




















